Advertisement

New Definition of Obesity Led to Increased Prevalence of Obesity

0

Prevalence increased to 68.6 percent with new criteria, which include anthropometric measures such as waist circumference, waist-to-hip ratio, waist-to-height ratio

Stronger Grip Strength Protects Against Obesity-Related Outcomes

0

Authors say findings underscore the importance of improving muscle mass and strength in at-risk people

New Diagnosis Code Added for Patients With Type 2 Diabetes in Remission

0

New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic range below 6.5% for at least three months

ACS: 2020 to 2024 Saw Jump in Use of GLP-1 Receptor Agonists Before Metabolic,...

0

Even higher use seen in patients without type 2 diabetes

Rates of Physician Attrition From Clinical Practice Have Risen Since 2013

0

Rates of attrition up for male and female physicians, in rural and urban settings, across specialties, across geographic regions

Continuous Glucose Monitors Not Accurate in People Without Diabetes

0

Authors say in those without diabetes, continuous glucose monitors are not a substitute for HbA1c

Weight-Loss Treatment Tied to Lower Risk for Obesity-Related Cancers

0

Findings seen for both medication and surgical procedures in people with obesity and type 2 diabetes

12.4 Percent of Older Adults Have Ultraprocessed Food Addiction

0

Men and women reporting overweight, respectively, are 19.14 and 11.44 times more likely to meet criteria for UPF addiction

Costco to Sell Ozempic and Wegovy for $499 a Month

0

The same price is already available on Novo Nordisk’s direct-to-consumer website, as well as at Walmart and CVS

Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists

0

Findings seen for long-term outcomes among adult patients with diabetes and obesity